Publication: Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG-positive NMOSD
| dc.contributor.coauthor | Siriratnam, Pakeeran | |
| dc.contributor.coauthor | Huda, Saif | |
| dc.contributor.coauthor | Van Der Walt, Anneke | |
| dc.contributor.coauthor | Sanfilippo, Paul G. | |
| dc.contributor.coauthor | Sharmin, Sifat | |
| dc.contributor.coauthor | Foong, Yi Chao | |
| dc.contributor.coauthor | Yeh, Wei Z. | |
| dc.contributor.coauthor | Zhu, Chao | |
| dc.contributor.coauthor | Khoury, Samia J. | |
| dc.contributor.coauthor | Csepany, Tunde | |
| dc.contributor.coauthor | Willekens, Barbara | |
| dc.contributor.coauthor | Etemadifar, Masoud | |
| dc.contributor.coauthor | Özakbaş, Serkan | |
| dc.contributor.coauthor | Nytrova, Petra | |
| dc.contributor.coauthor | Al-Asmi, Abdullah | |
| dc.contributor.coauthor | Ramo-Tello, Cristina M. | |
| dc.contributor.coauthor | Laureys, Guy | |
| dc.contributor.coauthor | Patti, Francesco | |
| dc.contributor.coauthor | Horakova, Dana | |
| dc.contributor.coauthor | Foschi, Matteo | |
| dc.contributor.coauthor | Boz, Cavit | |
| dc.contributor.coauthor | Mccombe, Pamela A. | |
| dc.contributor.coauthor | Türkoğlu, Recai | |
| dc.contributor.coauthor | Lechner-Scott, Jeannette | |
| dc.contributor.coauthor | Roos, Izanne | |
| dc.contributor.coauthor | Kalincik, Tomas | |
| dc.contributor.coauthor | Jokubaitis, Vilija G. | |
| dc.contributor.coauthor | Butzkueven, Helmut | |
| dc.contributor.coauthor | Monif, Mastura | |
| dc.contributor.department | KUTTAM (Koç University Research Center for Translational Medicine) | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.facultymember | Yes | |
| dc.contributor.kuauthor | Altıntaş, Ayşe | |
| dc.contributor.schoolcollegeinstitute | Research Center | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.date.accessioned | 2025-03-06T20:59:45Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Objectives: In aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD), disability accrual is mostly attributed to relapses. This study aimed to assess the prevalence of progression independent of relapse activity (PIRA) and relapse-associated worsening (RAW) in AQP4-IgG NMOSD. Methods: This was a retrospective cohort study of patients with AQP4-IgG NMOSD enrolled in the MSBase international data registry. Patients required a minimum of 3 recorded Expanded Disability Status Scale (EDSS) scores: baseline, event, and a 6-month confirmation score. Presence and absence of relapses between the baseline and event EDSS scores determined RAW and PIRA, respectively. Descriptive statistics were used to present the results. Results: A total of 181 patients followed for a median of 4.5 years (Q1 1.7, Q3 7.8) were included. Most patients were female (88.4%), and the median age at disease onset was 38.1 years. Overall, 4 patients (2.2%) developed 5 incidences of PIRA and 13 patients developed RAW (7.2%). Discussion: This multicenter study highlights that PIRA is very rare in AQP4-IgG NMOSD. Limitations of this study include the sole focus of overall EDSS to measure disability, lack of requirement for a second EDSS score to confirm baseline EDSS, and the absence of magnetic resonance imaging information for all patients. | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.indexedby | Scopus | |
| dc.description.indexedby | PubMed | |
| dc.description.openaccess | N/A | |
| dc.description.peerreviewstatus | N/A | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.studentonlypublication | No | |
| dc.description.studentpublication | No | |
| dc.description.version | N/A | |
| dc.identifier.WoSQuartile | Q1 | |
| dc.identifier.doi | 10.1212/WNL.0000000000209940 | |
| dc.identifier.eissn | 1526-632X | |
| dc.identifier.embargo | N/A | |
| dc.identifier.issn | 0028-3878 | |
| dc.identifier.issue | 12 | |
| dc.identifier.pubmed | 39561307 | |
| dc.identifier.scopus | 2-s2.0-85210113292 | |
| dc.identifier.uri | https://doi.org/10.1212/WNL.0000000000209940 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/27754 | |
| dc.identifier.volume | 103 | |
| dc.identifier.wos | 001525905700001 | |
| dc.keywords | Neuromyelitis optica | |
| dc.keywords | Disability progression | |
| dc.keywords | Relapse activity | |
| dc.keywords | Aquaporin-4 antibodies | |
| dc.language.iso | eng | |
| dc.publisher | Lippincott Williams and Wilkins | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Neurology | |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.subject | Clinical neurology | |
| dc.title | Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG-positive NMOSD | |
| dc.type | Other | |
| dc.type.other | Editorial material | |
| dspace.entity.type | Publication | |
| local.contributor.kuauthor | Altıntaş, Ayşe | |
| relation.isOrgUnitOfPublication | 91bbe15d-017f-446b-b102-ce755523d939 | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 91bbe15d-017f-446b-b102-ce755523d939 | |
| relation.isParentOrgUnitOfPublication | d437580f-9309-4ecb-864a-4af58309d287 | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | d437580f-9309-4ecb-864a-4af58309d287 |
